Department of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beixian'ge Street No. 5 Xicheng District, Beijing, China.
Graduate school, Beijing University of Chinese Medicine, Beijing, China.
BMC Cancer. 2023 Sep 19;23(1):884. doi: 10.1186/s12885-023-11392-2.
The relationship between sleep disturbances and lung cancer is complex and bidirectional. This meta-epidemiological study aimed to explore the potential association between sleep disruption and the risk of pulmonary cancer.
We conducted a comprehensive literature search of the PubMed, Embase, Cochrane Library, and Web of Science databases to retrieve relevant studies. We employed the Newcastle-Ottawa Scale to assess the quality of the observational studies. Stata 17.0 was used to synthesize and conduct a meta-analysis of odds ratios (ORs) and corresponding 95% confidence intervals (CIs). We used funnel plot analysis and Egger's regression test to evaluate potential publication bias.
A total of 11 studies were included with 469,691 participants. The methodological quality of the included studies ranged from moderate to high. Compared with 7-8 h of sleep time, short sleep duration was associated with a 13% higher lung cancer risk [OR, 1.13; 95%CI: 1.02-1.25; I = 67.6%; P = 0.018] and long sleep duration with a 22% higher risk [OR, 1.22; 95%CI: 1.12-1.33; I = 6.9%; P < 0.001]. Insomnia symptoms [OR, 1.11; 95%CI: 1.07-1.16; I = 0%; P < 0.001] and evening chronotype [OR, 1.15; 95%CI: 1.05-1.26; P = 0.002] were all related to a higher risk of lung cancer. Egger's test revealed no publication bias for sleep duration (P = 0.13).
This systematic review is the first one which observes positive correction between sleep disturbances and the incidence of lung cancer. While the plausible mechanism is not clear, it is hypothesized that the association of short sleep duration and lung cancer mainly mediated by melatonin secretion and the immune-inflammatory balance. Further studies are needed to examine whether other risk factors, such as age, occupation, cumulative effect of sleep disturbances might mediate the relationship between sleep disturbances and lung cancer risk.
The present study revealed that insufficient and excessive sleep duration, insomnia symptoms, and evening chronotype were significantly predictive of an increased risk of lung cancer. This finding underscores the need to account for sleep disturbances as an independent risk factor for evaluating susceptibility to lung cancer.
CRD42023405351.
睡眠障碍与肺癌之间的关系复杂且相互影响。本项荟萃流行病学研究旨在探讨睡眠中断与肺癌风险之间的潜在关联。
我们全面检索了 PubMed、Embase、Cochrane 图书馆和 Web of Science 数据库中的相关文献,使用纽卡斯尔-渥太华量表评估观察性研究的质量。采用 Stata 17.0 软件对优势比(ORs)及其相应的 95%置信区间(CIs)进行合并和荟萃分析。我们采用漏斗图分析和 Egger 回归检验评估潜在的发表偏倚。
共纳入 11 项研究,涉及 469691 名参与者。纳入研究的方法学质量从中等到较高。与睡眠时间为 7-8 小时相比,睡眠不足与肺癌风险增加 13%相关[OR,1.13;95%CI:1.02-1.25;I=67.6%;P=0.018],而睡眠过多与肺癌风险增加 22%相关[OR,1.22;95%CI:1.12-1.33;I=6.9%;P<0.001]。失眠症状[OR,1.11;95%CI:1.07-1.16;I=0%;P<0.001]和晚型生物钟[OR,1.15;95%CI:1.05-1.26;P=0.002]均与肺癌风险增加相关。Egger 检验显示,睡眠时间的发表偏倚无统计学意义(P=0.13)。
这是第一项观察睡眠障碍与肺癌发病率之间存在正相关关系的系统评价。虽然其潜在机制尚不清楚,但推测睡眠持续时间较短与肺癌之间的关联主要通过褪黑素分泌和免疫炎症平衡来介导。需要进一步研究以确定其他风险因素(如年龄、职业、睡眠障碍的累积效应)是否会调节睡眠障碍与肺癌风险之间的关系。
本研究表明,睡眠时间不足和过多、失眠症状和晚型生物钟与肺癌风险增加显著相关。这一发现强调了将睡眠障碍作为评估肺癌易感性的一个独立危险因素的必要性。
CRD42023405351。